The challenge is that Vertex has not submitted an application, nor is it in negotiations with Canada to market this product. However, we do have the special access program that the member may be aware of. In fact, out of 98 patients who applied for special access to Trikafta, 95 were approved as of May 6.
On May 14th, 2020. See this statement in context.